Spectrum Pharmaceuticals Stock News

In last trading session, Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) saw 12.69 million shares changing hands with its beta currently measuring 1.89. Companys recent per share price level of $1.68 trading at $0.1 or 6.33% at ring of the bell on the day assigns it a market valuation of $278.53M. That closing price of SPPIs stock is Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) Is Expected To Grow By Or More Than -495.24%. Read More »

Top penny stocks traders decided to buy today but are they worth the risk? The post 4 Top Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto

Spectrum Pharmaceuticals, Inc. (SPPI) shares closed 2.6% higher than its previous 52 week low, giving the company a market cap of $259M. The stock is currently down 53.7% year-to-date, down 66.6% over the past 12 months, and down 60.4% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.6%. Trading Activity Trading volume this week was 3.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -7643.3% The company's stock price performance over the past 12 months lags the peer average by -322.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) traded at $1.58 at close of the session on Monday, 11/29/21, made a downward move of -6.51% on its previous days price. Looking at the stock we see that its previous close was $1.69 and the beta (5Y monthly) reads 2.27 with the days price range being $1.535 $1.7364. In Take A Look At This Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Analysis Before You Invest Read More »

Spectrum Pharmaceuticals, Inc. (SPPI) shares closed today at 1.2% above its 52 week low of $1.67, giving the company a market cap of $277M. The stock is currently down 50.4% year-to-date, down 62.9% over the past 12 months, and down 61.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 564.9% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -2318.9% The company's stock price performance over the past 12 months lags the peer average by -276.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Nuveen Asset Management LLC lessened its stake in shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) by 23.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 482,516 shares of the biotechnology companys stock after selling 149,616 shares during the period. Nuveen []

Cubist Systematic Strategies LLC grew its holdings in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) by 1,009.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 110,539 shares of the biotechnology companys stock after purchasing an additional 100,578 shares during the quarter. Cubist Systematic Strategies []

Squarepoint Ops LLC cut its stake in shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) by 13.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 93,906 shares of the biotechnology companys stock after selling 14,206 shares during the period. Squarepoint Ops LLC owned about 0.06% of []

Spectrum Pharmaceuticals (NASDAQ:SPPI) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a report issued on Wednesday, Zacks.com reports. The firm presently has a $2.25 target price on the biotechnology companys stock. Zacks Investment Researchs target price would indicate a potential upside of 12.50% from the companys previous close. []

B. Riley reiterated their buy rating on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) in a report released on Friday morning, Zacks.com reports. Several other research analysts have also recently issued reports on SPPI. JMP Securities reissued a buy rating and set a $4.00 target price on shares of Spectrum Pharmaceuticals in a report on Monday, September []

Analysts expect that Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) will report earnings per share (EPS) of ($0.29) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have made estimates for Spectrum Pharmaceuticals earnings, with estimates ranging from ($0.29) to ($0.28). Spectrum Pharmaceuticals reported earnings per share of ($0.36) in the same quarter last year, which []

Spectrum Pharmaceuticals, Inc.'s (SPPI) CEO Joseph Turgeon on Q3 2021 Results - Earnings Call Transcript

5 penny stocks to watch right now. The post Best Penny Stocks To Buy Now?

New York, New York--(Newsfile Corp. - October 19, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a se

New York, New York--(Newsfile Corp. - October 19, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Spectrum Pharmaceuticals, Inc. (NASDAQ: